CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk› Healthcare› IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals & Pharmaceuticals Ltd

BSE 524164 IOLCP INE485C01029
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

23 filings · 6 material · busiest 2026-08-07

What it files

Newspaper Publication4 General4 Analyst / Investor Meet2 Concall Transcript1 Investor Presentation1 Board Outcome1 Results1 Press Release1

Filings

23 in the window

  1. 20 August 2026

    Concall Transcript

    Earnings Call Transcript

    Earning Call Transcript

    Company Update / Earnings Call Transcript View filing →

  2. 18 August 2026

    Newspaper Publication

    Newspaper Publication

    Submission of Newspaper Publication

    Company Update / Newspaper Publication View filing →

  3. 13 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q1- FY2027

    Company Update / Analyst / Investor Meet View filing →

  4. 12 August 2026

    Investor Presentation

    Investor Presentation

    Investor Presentation

    Company Update / Investor Presentation View filing →

  5. 11 August 2026

    Newspaper Publication

    Newspaper Publication

    Submission of newspaper publication of unaudited Financial Results for the quarter ended 30th June 2026

    Company Update / Newspaper Publication View filing →

  6. 11 August 2026

    General

    Communication To The Shareholders Regarding AGM Notice And Annual Report For The Financial Year 2025-26

    Communication to the Shareholders regarding AGM Notice ansd Annual Report for the Financial Year 2025-26

    Company Update / General View filing →

  7. 10 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026

    Outcome of the Board Meeting and submission of Unaudited Financial Results of the Company for the quarter ended 30th June 2026

    Board Meeting / Outcome of Board Meeting View filing →

  8. 10 August 2026

    Results

    Outcome Of The Board Meeting And Submission Of Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026

    Submission of Unaudited Financial Results of the Company for the quarter ended 30th June 2026

    Result / Financial Results View filing →

  9. 10 August 2026

    Press Release

    Press Release / Media Release

    Press Release- Financial Results for the quarter ended 30th June 2026

    Company Update / Press Release / Media Release View filing →

  10. 7 August 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Submission of Integrated Annual Report for FY 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  11. 7 August 2026

    AGM / EGM

    Submission Of Notice Of The 39Th Annual General Meeting

    Notice of 39th Annual General Meeting

    AGM/EGM / AGM View filing →

  12. 7 August 2026

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    Submission of BRSR FY 2025-26

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  13. 7 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Schedule of analyst / investor conference call - Q1 FY27

    Company Update / Analyst / Investor Meet View filing →

  14. 3 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication

    Company Update / Newspaper Publication View filing →

  15. 3 August 2026

    Board Meeting

    Board Meeting Intimation for Notice Of Board Meeting

    IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Un-audited ....

    Board Meeting / Board Meeting View filing →

  16. 14 July 2026

    General

    Approval From NMPA, China For Clopidogrel Bisulfate API

    Approval from NMPA,China foe Clopidogrel Bisulfate API

    Company Update / General View filing →

  17. 8 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of SEBI(DP) Regulations,2018

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  18. 1 July 2026

    Credit Rating

    Credit Rating

    Reaffirmation of Credit Rating

    Company Update / Credit Rating View filing →

  19. 29 June 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NM Merchantiles Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  20. 25 June 2026

    Trading Window

    Closure of Trading Window

    Intimation of Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  21. 19 June 2026

    Newspaper Publication

    Newspaper Publication

    Submission of newspaper publication

    Company Update / Newspaper Publication View filing →

  22. 11 June 2026

    General

    Communication To Shareholders Relating To Unclaimed Dividend

    Intimation regarding communication to shareholders relating to unclaimed dividend

    Company Update / General View filing →

  23. 10 June 2026

    General

    Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Company Update / General View filing →